desloratadine has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xie, Z; Yang, YX; Zhang, H | 1 |
| Ge, S; He, H; He, L; Hou, Y; Li, X; Wang, C | 1 |
2 other study(ies) available for desloratadine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Mask-induced contact dermatitis in handling COVID-19 outbreak.
Topics: Anti-Inflammatory Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Dermatitis, Allergic Contact; Desonide; Facial Dermatoses; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Isocyanates; Loratadine; Masks; Pandemics; Patch Tests; Pneumonia, Viral; SARS-CoV-2; Young Adult | 2020 |
Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis.
Topics: Angiotensin-Converting Enzyme 2; Binding Sites; Cell Survival; COVID-19; HEK293 Cells; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Molecular Docking Simulation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Surface Plasmon Resonance; Virus Internalization | 2021 |